Serum Biomarkers in Restless Legs Syndrome: Beyond the Classical Iron Paradigm—A Scoping Review
International Journal of Molecular Sciences · 09.04.2026 · 27 (8) · 3385
DOI: 10.3390/ijms27083385 ↗Kurz gefasst
Scoping Review in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.04.2026. Verfasst von Krasimir Avramov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Restless Legs Syndrome, Biomarkers, Iron. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University Plovdiv.
Abstract (Originalsprache)
Restless legs syndrome (RLS) is one of the most prevalent sleep disorders, yet its diagnosis continues to rely almost entirely on subjective symptom descriptions. This persistent dependence on phenomenology reflects the absence of reliable biological markers to aid in the process of diagnosis or monitoring. However, there is accumulating molecular evidence that suggests that RLS is associated with systemic biological alterations. These extend beyond the traditional paradigm of iron deficiency. The present scoping review synthesizes the current research on circulating serum biomarkers investigated in RLS outside classical iron indices. A comprehensive search of PubMed, Scopus, and Web of Science databases identified 1050 records, of which 50 studies met eligibility criteria and were included. In the processing of data, clusters emerged into several recurring biological domains, including dysregulated iron regulatory signaling (hepcidin), low-grade immune activation, oxidative stress, and neuroaxonal injury markers. High-throughput omics studies reveal molecular network perturbations involving inflammatory pathways, complement activation, metabolic signaling, and cellular stress responses. Biomarker associations appear stronger when linked to objective motor burden. These findings suggest that RLS may involve multifarious molecular changes detectable in the serum. Consequently, this can support the transition from symptom-based diagnosis toward biomarker-informed stratification, which may enable more precise disease characterization and improved diagnostic accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
ORCID-Profile: Kiril Terziyski
Förderung
- Medical University Plovdiv
Zitieren
APA
Avramov, K., Georgiev, T., Draganova, A., & Terziyski, K. (2026). Serum Biomarkers in Restless Legs Syndrome: Beyond the Classical Iron Paradigm—A Scoping Review. International Journal of Molecular Sciences, 27(8), 3385. https://doi.org/10.3390/ijms27083385
Vancouver
Avramov K, Georgiev T, Draganova A, Terziyski K. Serum Biomarkers in Restless Legs Syndrome: Beyond the Classical Iron Paradigm—A Scoping Review. International Journal of Molecular Sciences. 2026;27(8):3385. doi:10.3390/ijms27083385
BibTeX
@article{Avramov2026,
author = {Avramov, Krasimir and Georgiev, Todor and Draganova, Aneliya and Terziyski, Kiril},
title = {Serum Biomarkers in Restless Legs Syndrome: Beyond the Classical Iron Paradigm—A Scoping Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {8},
pages = {3385},
doi = {10.3390/ijms27083385}
}
EUVIMED